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CHAPTER 1 
 
Analysis of mouse renal proteins involved in Klotho deficiency by 
using MALDI imaging mass spectrometry 
 
 
 
1. Abstract 
 
The recent development of matrix-assisted laser desorption/ionization-imaging mass 
spectrometry (MALDI-IMS) approaches has enabled determination of the detailed 
spatial distribution of molecules in frozen tissues. However, consistent detection of 
various species using MALDI-IMS approaches has not been achieved. Thus, this study 
was conducted to determine whether a combination method involving liquid 
chromatography (LC)-MS-MS and MALDI-IMS with trypsin digestion could be used to 
evaluate spatial distribution using cryosections from wild-type (WT) and Klotho 
knockout (kl-/-) mouse kidneys. MALDI-IMS (m/z, mass-to-charge ratio; 1000–60,000) 
of frozen kidney tissues collected from 7-week-old male WT and kl-/- mice was used to 
determine genotype-specific differences of the MS distribution. Neighboring sections 
were subjected to MALDI-IMS (m/z 600–6000) and LC-MS-MS after trypsinization, 
and the distribution of molecules identified by LC-MS-MS were reflected by 
MALDI-IMS. As a result, titin, a very large protein (approximately 3800 kDa) was 
successfully detected. Sixty-one and 33 proteins were detected in only WT and kl-/- 
mouse kidneys, respectively. Among these, high mobility group protein B1, thymosin 
β4, and RAD51-associated protein 1 from WT and fructose bisphosphate aldolase A, 
chromogranin A and secretogranin-1 from kl-/- were originally linked to the morbid state 
in kl-/- mice. Additionally, secretogranin-1 was highly detected in the glomeruli, renal 
tubules, and blood vessels of kl-/- mouse kidneys by immunohistochemistry. These 
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results showed that a combination of MALDI-IMS and LC-MS-MS with trypsin 
digestion is useful for visualizing and identifying novel pathologic proteins in frozen 
tissues. 
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2. Introduction 
 
Recently, omics approaches have been actively used to explore variations in whole 
molecules constituting an organism and analyzing life activity and pathogenesis. 
Anomalies in protein expression, distribution, and metabolism are frequently observed 
in pathological conditions; therefore, information obtained from proteomics and 
metabolomics studies has become particularly important for elucidating the etiology and 
for diagnosis. Conventional imaging techniques such as immunohistochemistry require 
labeling and show difficulties in discovering new pathological molecules in the tissue. 
Mass spectrometry (MS) is a commonly used technology for detecting analytes in 
proteomics and metabolomics research and can directly define individual molecular 
species in intricate samples, thus broadening our understanding of biological molecules; 
however, liquid chromatography (LC)-MS or gas chromatography (GC)-MS analyses 
require the use of tissue homogenates, and thus, all tissue localization information is 
lost.  
 
Among the several MS ionization techniques used for direct tissue analysis, 
matrix-assisted laser desorption/ionization (MALDI)-MS is a powerful tool because of 
its wide detection range of biomolecules [1, 2]. Imaging by MALDI-MS (MALDI-IMS) 
reveals the detailed spatial distribution of molecules in biological samples [3]. In 
MALDI-IMS, however, consistent detection of species over 25 kDa has not been 
achieved [4]. To overcome this limitation, proteins with high molecular mass are 
digested by proteolytic enzymes such as trypsin, pepsin, and formic acid, and MS-MS is 
carried out in situ following protease digestion of tissue sections [5, 6]. This MS-MS 
approach must be performed under optimal spotting conditions for digestion and often 
exhibits poor digestion efficiency because of the small droplets of enzyme solution 
present. To overcome this limitation, digestive extraction from neighboring sections 
were applied liquid chromatography (LC)-MS-MS to identify the proteins present, 
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followed by MALDI-IMS analysis. 
 
Aging rodents exhibit significantly lower renal α-Klotho (Klotho) protein expression 
than do young rodents [7]. The klotho gene was serendipitously identified as a gene 
mutated in a mouse strain (kl/kl mice) suffering from a syndrome resembling 
accelerated human aging, including atrophy of the genital organs and thymus, 
arteriosclerosis, ectopic calcification, and osteoporosis [8]. Klotho is a single-pass 
transmembrane glycoprotein that is predominantly expressed in the distal convoluted 
tubules, choroid plexus of the brain, and parathyroid glands [8, 9]. Klotho protein forms 
constitutive binary complexes with multiple fibroblast growth factor (FGF) receptors 
(FGFR1c, 3c, and 4), selectively increasing their affinity to FGF23 [10], which is 
mainly derived from osteolineage cells [11]. Klotho also acts to maintain homeostasis in 
phosphate and vitamin D metabolism by regulating the sodium phosphate co-transporter 
and vitamin D-metabolizing enzymes in the kidneys [12]. Partial deletion of Klotho in 
the distal tubules increases the renal protein expression of vitamin D receptor and 
sodium-dependent phosphate transport protein 2A [13]. Recent studies have also 
reported the function of circulating soluble Klotho. Soluble Klotho is generated by 
cleavage [14] and can act as a paracrine or endocrine mediator independently of the 
FGF23 pathways by promoting renal calcium reabsorption through stabilization of the 
transient receptor potential vanillid-5 channel in the distal tubules and by reducing 
serum levels of 1,25-dihydroxyvitamin D3 [15]. These previous findings provide limited 
evidence for a pathogenic role of Klotho in altering the production and/or distribution of 
several proteins involved in aging-related disorders such as chronic kidney disease 
(CKD) and kidney stones. 
 
Here, this study conducted comparative proteome analysis of sections from wild-type 
(WT) and Klotho knockout (kl-/-) mouse kidneys to identify novel pathologic proteins 
using a combination of MALDI-IMS and LC-MS-MS. 
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3. Materials and Methods 
 
3.1. Materials 
Conductive indium tin oxide (ITO)-coated glass slides (100 Ω) were purchased from 
Matsunami Glass Ind., Ltd., (Osaka, Japan). Trypsin was purchased from Promega KK 
(Tokyo, Japan). Sinapic acid (SA) and α-cyano-4-hydroxycinnamic acid matrix were 
purchased from Bruker Daltonics (Bremen, Germany). Acetonitrile (ACN) was 
purchased from Merck (Darmstadt, Germany). Carboxymethylcellulose (CMC, 2%) 
was purchased from Leica Microsystems (Wetzlar, Germany). Trifluoroacetic acid 
(TFA), 2,5-dihydroxy-benzoic acid (DHB), and all other chemicals, unless otherwise 
specified, were purchased from Sigma–Aldrich Co. (St. Louis, MO).  
 
3.2. Animals 
Klotho heterozygous mice (kl-/+) were purchased from CLEA, Inc. (Osaka, Japan). kl-/- 
mice were obtained by mating kl-/+ mice. Mice were housed and handled to minimize 
pain or discomfort to the animals according to the protocols approved by the 
Institutional Animal Care and Use Committee at the Central Institute for Experimental 
Animals and the Committee of Animal Experimentation at Hiroshima University. 
Genotyping of Klotho knockout mice and Klotho WT mice was conducted as described 
previously [16]. 
 
3.3. Specimen preparation 
Seven week-old male WT and kl-/- mice were euthanized and whole kidneys were 
extracted. For MALDI-IMS, LC-MS-MS, and immunohistochemistry, the kidneys were 
rapidly embedded in a stainless steel container filled with 2% CMC and then placed in 
dry ice-cooled hexane to form frozen CMC blocks. Each frozen block was stored at 
−80°C until sectioning. Tissues were sectioned (10 µm) using a CM 3050 S cryostat 
(Leica) and placed on the ITO-coated slides, followed by washing with 70% ethanol 
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and 100% ethanol and drying.  
 
3.4. Trypsin digestion 
After washing and drying of the neighboring sections (one for MALDI-IMS and another 
for LC-MS-MS), 200 µL of trypsin solution (100 ng/µL in 40 mM ammonium 
bicarbonate: ACN = 9:1) was applied in an ImagePrepTM device (Bruker Daltonics) 
using the standard SA method and then the sections were placed in tubes under 100% 
relative humidity conditions at 37°C for 90 min.  
 
3.5. MALDI-IMS 
The matrix solutions composed of 10 mg/mL SA in 60% ACN (0.2% TFA) or 30 
mg/mL DHB in 50% methanol (1% TFA), for trypsinized or untrypsinized sections, 
respectively, were evenly sprayed onto the sections using an ImagePrepTM device using 
the standard SA method. MALDI images were acquired using the UltrafleXtreme 
MALDI-TOF mass spectrometer (Bruker Daltonics) in linear positive ion mode in a 
range of m/z (mass-to-charge ratio) of 1000–60,000 or 600–6000 for untrypsinized or 
trypsinized sections, respectively. A spatial resolution of 35 µm was used. For 
positioning of the glomeruli and renal tubules, neighboring sections were subjected to 
hematoxylin-eosin (HE) staining. 
 
3.6. LC-MS-MS 
Peptides from tryptic digests on the slides were reconstituted in 0.1% TFA, separated, 
and analyzed by LC-MS-MS using an EASY-nLC system (Bruker Daltonics) coupled 
to an ultraflextreme TOF/OTF with Smartbeam II (Bruker Daltonics). The LC system 
was configured with an L-column2 ODS (2 µm, 0.2φ × 50 mm, Chemicals Evaluation 
and Research Institute, Tokyo, Japan) for 65 min with a gradient of solvent A (0.1% 
TFA in H2O) and solvent B (ACN) at a flow rate of 0.9 µL/min. The gradient was 
performed as follows; 0–3 min 95% A and 5% B, then to 50% A and 50% B at 60 min, 
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5% A and 95% B from 61 to 64 min, and 95% A and 5% B at 65 min. A total of 248 
fractions were obtained from 3 to 65 min and subjected to MS and MS-MS analysis. 
MS-MS data were evaluated using the Mascot search engine (version 2.4.1, Matrix 
Sciences, London, UK) for protein identification. The protein list was also functionally 
evaluated applying UniProtKB (http://www.uniprot.org/). 
 
3.7. Immunohistochemistry 
For immunofluorescence staining, frozen sections (5 µm) were prepared as described 
above and perfused with 4% paraformaldehyde phosphate-buffered saline (PBS) for 3 
min. Briefly, the sections were rinsed for 5 min with PBS, incubated in washing buffer 
(PBS containing 50 mM NH4Cl) for 10 min, and incubated in blocking buffer (washing 
buffer containing 2% bovine serum albumin and 0.05% saponin) for 20 min. The 
sections were incubated with goat polyclonal anti-chromogranin B antibody (1:100, 
Santa Cruz Biotechnology, Inc., Santa Cruz, CA) overnight at 4°C. After 3 × 5 min of 
washing with PBS, the sections were incubated in CyTM3-conjugated donkey anti-goat 
IgG (1:400; Jackson ImmunoResearch Lab, West Grove, PA) for 1 h at room 
temperature. Antibody specificity was also evaluated using blocking peptide (1:20, 
Santa Cruz Biotechnology). DAPI staining was also performed for counterstaining. 
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4. Results 
 
4.1. Comparison of MS distribution between WT and kl-/- mouse kidneys by 
MALDI-IMS without trypsin digestion 
To identify proteins showing differential distributions between genotypes, the average 
mass spectra of cryosections from both kidneys were compared. Among the setting 
measurement ranges (m/z 1000–60,000), the mass spectrum of the good S/N ratio was 
detected up to approximately m/z 16,000 in both genotypes (Figure 1A, B). According 
to MALDI-IMS, more than 30 proteins were differentially distributed between 
genotypes; for example, a molecule at m/z 14,978.85 was strongly detected in the WT 
but not in kl-/- mouse kidneys (Figure 1C), and a molecule at m/z 13,990.64 was strongly 
detected in kl-/- but not in WT mouse kidneys (Figure 1D). 
 
4.2. Detection and identification of proteins using a combination of MALDI-IMS and 
LC-MS-MS after trypsinization  
To check evaluate whether the combination method of MALDI-IMS and LC-MS-MS is 
useful, the cryosections were trypsinized and then subjected to MALDI-IMS (m/z 600–
6000) and LC-MS-MS. The number of detectable mass spectra was increased by 
digestion in both genotypes in MALDI-IMS analysis (Figure 2A–D). A total of 103 and 
76 proteins were identified when the sequences were aligned to LC-MS-MS spectra in 
the Mascot database, and of these, 97 and 69 proteins were matched to MALDI-IMS 
spectra in the WT and kl-/- mouse kidney, respectively. Sixty-one and 33 proteins were 
detected in only the WT and kl-/- mouse kidney, respectively (Table 1A, B). High 
mobility group protein B1 (HMGB1), thymosin β4, RAD51-associated protein 1 
(R51A1), superoxide dismutase (Table 1A), Wnt5, fructose bisphosphate aldolase A, 
chromogranin A (CMGA), and secretogranin-1 (SCG1) (Table 1B) may contribute to 
renal pathology in kl-/- mice (see Discussion). Thirty-six proteins were detected in both 
genotypes (Table 1C). Among the identified proteins, titin was the largest 
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(approximately 3900 kDa, Table 1A).   
 
Based on functional classification, nucleic acid binding proteins were the most 
frequently detected (42% in WT and 37% in kl-/-), followed by enzymes (20% in WT 
and 28% in kl-/-) (Figure 3). Membrane proteins and secretory proteins were also 
observed, and the number different protein types did not show a marked difference 
between genotypes. 
 
4.3. SCG1 localization at glomeruli, proximal and distal renal tubules in kl-/- mice  
To compare the localization in detail, the irradiation ranges were set to the glomeruli 
and proximal and distal renal tubules referring to the neighboring sections stained with 
HE (Figure 4A). In WT mice, 8, 9, and 3 proteins were detected in the glomeruli and the 
proximal and distal renal tubules, respectively (Table 2A). Of these, 5 proteins 
including R51A1 were observed in only WT. However, in kl-/- mice, 21 proteins were 
detected in each area, and 11 proteins including ALDOA, CMGA, and SCG1 were 
observed in only kl-/- mice (Table 2B). Based on MALDI-IMS, m/z 1269.629 was 
identified as one of the fragments of SCG1 by LC-MS-MS in the glomeruli and the 
proximal and distal renal tubules (Table 3 and Figure 4A–C). 
 
To confirm the identification and distribution of SCG1 in the kl-/- mouse kidney, 
immunohistochemistry for SCG1 was performed. Compared to WT, SCG1 
immunoreactivity was strong in the glomeruli and the proximal and distal renal tubules 
as well as in the blood vessels in kl-/- mice (Figure 5A–D). These results support those 
obtained from the combination of MALDI-IMS and LC-MS-MS. 
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5. Discussion 
 
Previous studies have found changes in the expression of genes and proteins in 
klotho-deficient mice; however, the results were complex and clarifying the 
pathological mechanisms of kidney diseases in these mice is difficult. Olauson et al. 
(2012) showed that targeted deletion of Klotho in the kidney resulted in abundant 
expression of sodium-dependent phosphate transport protein 2A without tubular 
calcification on renal histology. Yoshida et al. (2002) demonstrated that the levels of 
vitamin D receptor mRNA and protein were slightly and significantly reduced, 
respectively, in kl-/- mouse kidneys, which is not in accordance with previous studies 
even with high serum levels of 1,25-dihydroxyvitamin D3 [13, 17-20]. This study 
comprehensively determined the proteomics of the kl-/- mouse kidney to identify novel 
pathologic factors with localization information using a combination of MALDI-IMS 
and LC-MS-MS.  
 
In this study 61 presumptive proteins were detectable in the WT mouse kidney but not 
in the kl-/- mouse kidney. HMGB1, a member of the high mobility group nuclear protein 
family, has the capacity to produce specific changes in the structure of target DNA; it is 
localized in the nucleus where it exerts transcriptional activities [21-23]. HMGB1 also 
acts as a paracrine/autocrine factor to control cell differentiation, proliferation, and 
disease pathogenesis [24]. Studies using a neutralizing antibody to HMGB1 
demonstrated that HMGB1 is an early mediator of injury and inflammation in the liver 
or kidney following ischemia-reperfusion [25, 26]. Thymosin β4, isolated originally 
from the calf thymus [27] and further detected in several organs, including the kidney 
[28], promotes the migration of endothelial cells, angiogenesis, and tumor metastasis in 
vitro and in vivo [29-32]. Previous studies using MALDI-IMS indicated that thymosin 
β4 was detected in colon carcinoma and pancreatic cancer [33, 34]. R51A1 is critically 
important for homologous recombination by interacting with both the RAD51 and 
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DMC1 recombinases in mitotic and meiotic cells [35-37]. R51A1 knockdown in human 
cells by RNA interference led to increased levels of genomic instability and decreased 
levels of DNA repair that decreased with age [37, 38] and RAD51 diminishes with age 
in kidney [39]. This study is the first to demonstrate that undetectable proteins, 
including HMGB1, thymosin β4, and R51A1, in the kl-/- mouse kidney may be related 
to syndromes resembling the acceleration of human aging in Klotho-deficient mice. 
Superoxide dismutase (SOD) is an anti-oxidant enzyme known to be associated with 
aging. Previous studies have found that Klotho increases the resistance to oxidative 
stress by upregulating the activity of a human SOD2 gene promoter [40] and that aged 
rats showed glomerulosclerosis and tubulointerstitial fibrosis with a significant decrease 
in both Klotho and mitochondrial SOD protein expression in the renal cortex [41, 42] 
and medulla [42]. These studies support our results showing that SOD is undetectable in 
the kl-/- mouse kidney.  
 
In contrast, 33 presumptive proteins were detectable in the kl-/- mouse kidney but not in 
WT mice. Among the Wnt family that controls a variety of processes such as cell fate 
specification, cell migration, and cell polarity [43], most members are upregulated 
during renal fibrosis [44]. The soluble form of Klotho inhibits Wnt signaling and 
immunoprecipitates with a number of Wnt isoforms, including Wnt5a [45]. Fructose 
bisphosphate aldolase A (ALDOA) is a key enzyme in glycolysis and contributes to 
various cellular functions and biological processes [46-48]. Based on evidence that 
ALDOA activates the Wnt signaling pathway in a GSK-3β-dependent manner [49], 
Klotho deficiency may contribute to renal pathological anomalies with 
ALDOA-involved Wnt signaling. CMGA and SCG1 (also known as chromogranin B) 
are the members of the granin family (secretogranins/chromogranins) that play an 
important role in the packaging and sorting of secretory products such as peptide 
hormones and neuropeptide in the trans-Golgi network [50]. Both CMGA and SCG1 
are present in many normal (e.g., adrenal medulla and paraganglion) and neoplastic (e.g., 
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pheochromocytomas and prolactinomas) tissues in the diffuse neuroendocrine system 
[51]. In addition to the important roles of CMGA and SCG1 as biomarkers for 
screening of neuroendocrine tumors [52, 53], previous studies have shown that CMGA 
levels in the serum were elevated in various disorders, including renal failure [54-56]. 
Cleavage of CMGA by thrombin inhibits angiogenesis in vitro and in vivo [57] and 
angiogenesis does not function in CKD [58]; thus, CMGA may be involved in the loss 
of the rich peritubular capillary network in CKD. Compared to CMGA, the 
physiological functions of SCG1 are not well known; however, angiotensin II, which 
has been implicated in the pathogenesis of various glomerular diseases [59, 60], 
increases rat cardiomyocyte Scg1 mRNA expression [61]. The detected proteins, Wnt5, 
ALDOA, CMGA, and SCG1, in the kl-/- mouse kidney may contribute to pathogenesis, 
and further studies are needed to evaluate the effects of these proteins in kl-/- mice. 
 
Proteomics by MALDI-MS enables the identification of pathological factors without 
labeling, but the size of proteins that can be detected without digestion or optimization 
of conditions is limited (<25 kDa) (see Introduction). In this study, using a 
combination of MALDI-IMS and LC-MS-MS after trypsinization, the number of MS 
peaks was increased and the extent of localization and immunohistochemistry was 
stable. Furthermore, titin, which is the largest protein in vertebrate striated muscles 
(approximately 3900 kDa) [62], was successfully detected. This method was also 
successfully used to identify novel pathological proteins. The MALDI-IMS method 
exhibits some limitations in the quantitative and qualitative analysis and should be 
further improved in future studies.    
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6. Figure Legends 
 
Figure 1. Comparison of MS distribution between WT and kl-/- mouse kidney by 
MALDI-IMS. Average mass spectra (m/z < 20,000) of cryosections from WT (A) and 
kl-/- (B) mouse kidney. The x-axis and the y-axis represent m/z and intensity, 
respectively. (C, D) The left and right images indicate WT and kl-/- mouse kidney, 
respectively. (C) Red spots indicate the molecule of m/z 14,978.85. (D) Green spots 
show the molecule of m/z 13,990.64. 
 
Figure 2. Comparison of average mass spectra between WT and kl-/- mouse kidney with 
or without trypsinization by MALDI-IMS. Average mass spectra (m/z 600–6000) of 
cryosections from WT (A, C) and kl-/- (B, D) mouse kidney with (C, D) or without (A, 
B) trypsin digestion. 
 
Figure 3. Functional classification of detected proteins. Identified proteins by the 
combination of MALDI-IMS and LC-MS-MS in WT (A) and kl-/- (B) were classified 
using UniProtKB. 
 
Figure 4. Distribution of a fragment of SCG1 in kl-/- mouse kidney by using a 
combination of MALDI-IMS and LC-MS-MS. (A) HE staining using the neighboring 
section. Blue, green, and yellow circles indicate glomeruli and proximal and distal renal 
tubules, respectively. (B) MALDI-IMS of m/z 1269.629. (C) Merged image of (A) and 
(B). 
 
Figure 5. Immunohistochemistry for SCG1 in WT and kl-/- mouse kidney. 
Immunofluorescence staining of SCG1 (A, C) and DAPI staining (B, D) in WT (A, B) 
and kl-/- (C, D) mouse kidney.  
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Table 1. List of proteins identified by a combination of MALDI-IMS and    
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Table 2. List of proteins identified from glomeruli, proximal, and distal      
        renal tubules  
A B 
* : the protein detected only in WT or kl
-/-
  
n = 2 ~ 5 
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Table 3. List of fragments of SCG1 
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Chapter 2 
 
Imaging and mapping of Klotho-deficient mouse bone using MALDI 
imaging mass spectrometry 
 
 
 
1. Abstract 
 
Matrix-assisted laser desorption/ionization-imaging mass spectrometry (MALDI-IMS) 
is a advanced method used globally for analyzing the distribution of biomolecules on 
tissue cryosections without any probes. Hydroxyapatite crystals in bones make it 
difficult to determine the distribution of biomolecules using MALDI-IMS, and there is 
limited information regarding the use of this method to analyze bones. To determine if 
MALDI-IMS analysis of bone tissues can aid in comprehensive mapping of 
biomolecules in mouse bone, and identify anomalous metabolites in the bone of 
Klotho-deficient (kl-/-) mice with osteopenia, first, the femurs and/or tibiae from 
8-week-old male mice were fixed and decalcified in various combinations of fixation 
and decalcification solutions. Fresh samples with or without decalcification were also 
prepared. About 10-µm thick cryosections were mounted on ITO-coated glass slides, 
dried, and matrix solution was splayed on the tissue surface. The images were acquired 
using iMScope (Shimadzu) within a mass-to-charge range of 100 to 1000. Adjacent 
sections were stained with Hematoxylin-Eosin, Alcian blue, Azan, and PAS to evaluate 
the histological and histochemical features. Femurs from kl-/- mice were 
fixed/decalcified in trichloroacetic acid (TCA) and used for MALDI-IMS and MS-MS 
analyses. The results were compared with those obtained for wild-type mice. Among 
various fixation and decalcification conditions, sections from TCA-treated samples 
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were most suitable to examine both the histology and comprehensive MS images. 
However, histotypic MS signals were detected in all sections. The MS-MS analysis 
revealed product ions that are unique to Klotho-deficient mice. In addition to the MS 
images, 2-hydroxyestradiol was identified as a candidate metabolite that is involved in 
skeletal defects of kl-/- mice. These results indicate successful detection of biomolecules 
in bone using MALDI-IMS. Although analytical procedures and compositional 
adjustment regarding the performance of the device still requires further development, 
IMS appears to be a powerful tool to determine the distribution of biomolecules even in 
the bone tissues.   
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2. Introduction 
 
Hard tissues such as bones and teeth are calcified tissues. Therefore, it is difficult using 
cellular and molecular analyses to investigate the function of cells such as osteocytes 
and cementocytes, and the distribution of organic matter such as proteins and peptides. 
For example, osteocytes, which terminally differentiate from osteoblasts and are 
embedded into the bone matrix play an important role in the maintenance of 
homeostasis in the network between osteoblasts and osteoclasts [1]. To confirm the 
physiological function of osteocytes, it is preferable to retain the original distribution of 
biomolecules when analyzed. In that context, matrix-assisted laser desorption/ionization 
imaging mass spectrometry (MALDI-IMS) is a useful method for investigation; 
MALDI-IMS enables analyzing the distribution of molecules without any disruption in 
the morphology and architecture. The benefit of MALDI-IMS for discovering the novel 
pathological molecules has already been described in Chapter 1. MALDI-IMS, 
however, has certain limitations for quantitative and qualitative uncertainty analysis. 
Additionally, there are few studies that used MALDI-IMS for bone tissues to identify 
the molecules because of the lack of appropriate methods to prepare sections for 
ionization [2-4]. Hirano et al. reported MALDI-IMS for tooth cryosections sliced by the 
Kawamoto method using adhesive film without any pretreatment such as fixation and 
decalcification [2]; however, the signals obtained from the enamel and dentin were not 
listed in the metabolomics database. They concluded that almost all of these signals are 
mineral, which can interrupt the ionization of the large components. Therefore, this 
study attempts to establish an appropriate protocol for the fixation and/or decalcification 
of samples derived from bone to detect MS using MALDI-IMS and provide a 
comprehensive mapping of proteins and peptides. 
 
Klotho gene mutation leads to a syndrome that is similar to accelerated human aging, 
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including ectopic calcification and osteoporosis [5] (see Chapter 1). Klotho acts as a 
cofactor for fibroblast growth factor (FGF) 23, which is mainly derived from the 
osteolineage cells [6] to increase the affinity of FGF23 to the FGF receptors [7]. The 
principle function of FGF23 is to maintain homeostasis in phosphate and vitamin D 
metabolism by regulating the sodium phosphate co-transporter and vitamin 
D-metabolizing enzymes in the kidneys [8], however, recent studies indicated that 
FGF23 directly regulates bone mineralization in both Klotho-dependent and 
independent manners [9, 10]. It was also reported that soluble Klotho, cleaved by A 
Desintegrin, as well as Metalloproteinase (ADAM) 10 and ADAM17 [11] acts to 
protect from uremic cardiomyopathy, inhibit renal inflammation, and suppress tumor 
growth independent of FGF23 [12-14]. In this study, we also attempt to identify 
anomalous metabolites in bone of Klotho-deficient (kl-/-) mice with osteopenia. 
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3. Materials and Methods 
 
3.1. Materials 
Conductive ITO (indium tin oxide)-coated glass slides (8-12 Ω) were purchased from 
Sigma–Aldrich Co. (St. Louis, MO). α-Cyano-4-hydroxycinnamic acid (CHCA) 
matrices were purchased from Bruker Daltonics (Bremen, Germany). 
Carboxymethylcellulose (CMC, 2 %) was purchased from Leica Microsystems (Wetzlar, 
Germany). Trifluoroacetic acid (TFA), 2,5-Dihydroxy-benzoic acid (DHB) and all other 
chemicals, unless otherwise specified, were purchased from Sigma–Aldrich Co.. 
 
3.2. Animals 
Klotho heterozygous (kl-/+) and C57BL/6J mice were purchased from CLEA Inc. (Osaka, 
Japan). kl-/- mice were obtained by mating the kl-/+ mice. Mice were housed and handled 
to minimize pain or discomfort to animals according to protocols approved by 
Institutional Animal Care and Use Committee at the Central Institute for Experimental 
Animals and the Committee of Animal Experimentation at Hiroshima University. 
Genotyping of Klotho knockout mice and Klotho wild-type was done as described [15]. 
 
3.3. Specimen preparation 
Femurs and/or tibiae from 8-week-old male mice (C57BL/6) were fixed and decalcified 
in various combinations of fixation and decalcification solutions (e.g., 4% 
paraformaldehyde (PFA), Carnoy fluid, trichloroacetic acid (TCA) for fixation; formic 
acid, EDTA-NH4, and TCA for decalcification) (see Table 1). Fresh samples with or 
without decalcification were also prepared. Samples were then embedded in a stainless 
steel container filled with 2% CMC and placed in dry ice-cooled hexane to make frozen 
CMC blocks. Each frozen block was stored at −80°C until sectioning. Tissues were 
sectioned (5 µm for staining and MALDI-IMS of fresh samples without any 
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pretreatment by Kawamoto method [16], and 10 µm for MALDI-IMS of samples with 
pretreatment) with a CM 3050 S cryostat (Leica Microsystems). For staining, sections 
were placed on the normal glass slides and washed with 100 % ethanol. For 
MALDI-IMS, sections were placed on Indium-tin-oxide (ITO)-coated glass slides (with 
electrically conducting double-adhesive tape for samples without pretreatment), 
followed by washing with 70 % ethanol and 100 % ethanol, and drying. Femurs from 
kl-/- mice were fixed/decalcified in TCA, followed by the same method as described 
above. 
 
3.4. Staining 
Adjacent sections were stained with Hematoxylin-Eosin (H-E), Alcian blue, Azan, and 
PAS to evaluate histological and histochemical features. Sections without fixation were 
fixed with 4% PFA. 
 
3.5. MALDI-IMS and MS-MS 
After cryosections were dried at room temperature, sections were coated with DHB or 
CHCA matrix vapor deposition using iMlayer (Shimadzu Corporation, Kyoto, Japan) at 
a thickness of 1.5 or 0.7 µm, respectively. MALDI images were acquired using 
iMScope (Shimadzu) in positive or negative ion mode in a range of m/z (mass-to-charge 
ratio) of 100 to 1000 at 1000 Hz laser frequency accumulating 50 laser shots. The 
detector voltage and sample voltage were 1.7 to 1.9 kV and 3.0 to 3.5 kV, respectively. 
Spatial resolution was 10 µm and laser intensity was 23 to 45. To omit the influence of 
fixing and decalcifying solutions and matrices, 1 µL of mixture of each solution and 
matrix was placed onto a stainless-steel (SUS) plate and supplied to iMScope after 
drying. Mass spectra obtained from this mixture were omitted from those from the 
samples. MS-MS data were evaluated using the Human Metabolome Database (HMDB) 
search engine (version 3.6, The Metabolomics Innovaton Centre, AB, Canada) for 
metabolite identification.   
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4. Results 
 
4.1. Histological and histochemical features of bones with or without pretreatment 
To evaluate the influence of fixing and/or decalcifying solutions on histological and 
histochemical features of femurs and tibiae, the cryosections were stained with H-E, 
Alcian blue, Azan, and PAS. Compared to the section without any pretreatment with 
H-E staining, (Figure 1A), cell swelling was seen and the shape of cells was unclear. 
Among various fixation and decalcification conditions, sections from TCA-treated 
samples were most suitable for examining both histology and comprehensive MS 
images (Figure 1B), followed by the samples decalcified with EDTA after fixation than 
others (Figures 1C, D). Bone marrows were peeled from trabecular bone surfaces in the 
samples with formic acid decalcification (Figures 1E, F). Cartilages in the growth plate 
and bone marrows were unable to keep their structure in samples with decalcification 
without fixation (Figures 1G, H). There was no difference between all samples with 
Azan and PAS staining. With Alcian Blue staining, however, bone marrows in unfixed 
and Carnoy/EDTA-treated samples turned dark blue (Figure 1 A, D, G, and H).  
 
4.2. Comparison of MALDI-IMS between bones with or without pretreatment 
To set up the measurement conditions of MALDI-IMS, all samples were supplied to 
iMScope in positive or negative ion mode with DHB or CHCA matrix. Among these, 
the condition of positive mode with DHB was enabled to detect many mass spectra in 
the wide range of m/z (Figure 2 A-D, in the case of sample with TCA treatment). 
Imaging by MALDI-IMS showed tissue-specific distribution of MS with DHB (Figure 
2E). Because the Kawamoto method requires cryofilm, MALDI-IMS of TCA-treated 
sections mounted on ITO-coated glass slide with or without cryofilm were analyzed to 
check the interference of cryofilm. With cryofilm, the number of mass spectra was 
much less than without cryofilm (Figure 2F, G). 
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In comparison of mass spectra detected in positive ion mode with DHB, the 
undecalcified sample with the Kawamoto method exhibited few peaks in the range of 
m/z 100-700 (Figure 3A). Each section has its own characteristic features of the 
appearance of peaks, but there was no significant difference in the obtained number of 
mass spectra between decalcified and/or fixed samples (Figures 3B-H).  
 
In MALDI-IMS, histotypic MS signals were detected in all sections. The signals of the 
molecule at m/z 554.57 was located mainly in bone marrows in all sections except the 
undecalcified section, and the molecule at m/z 185.13 was located mainly in cortical 
bones, trabecular bones, and cartilages in all sections except the Carnoy/formic acid 
sample (Figure 4). In the undecalcified section, there was a few signals at m/z 554.57 
(Figure 4A), and the signals at m/z 185.13 were localized diffusely in the 
Carnoy/formic acid sample (Figure 4F). 
 
By using Principal Component Analysis (PCA), a statistical method to extract the first 
principal component in variance between the samples, the first principal component was 
the same in the samples except the undecalcified, Carnoy/EDTA, and PFA/formic acid 
samples in the range of m/z 100-700 (Table 2).  
 
4.3. Metabolomics with WT and kl-/- mouse femurs 
To identify the anomalous metabolites in the bones of kl-/- mice, the TCA-treated 
sections from wild-type (WT) and kl-/- mouse femurs were applied to iMScope in 
positive ion mode with the DHB matrix. Several different mass spectra were obtained 
between genotypes in bones (Figure 5A, B), cartilages (Figure 5C, D), and bone 
marrows (Figure 5E, F). Because m/z 289.1 and m/z 300.1 were specifically located in 
the bones and cartilages of kl-/- mice femurs in MALDI-IMS (Figure 6), these two 
molecules were selected as precursor ions for MS-MS analysis to search the product 
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ions by using HMDB. As a result, m/z 289.1 and m/z 300.1 were identified as 
2-hydroxyestrdiol and sphingosine, respectively (Table 3), suggesting that these 
metabolites may be involved in skeletal defects in kl-/- mice. 
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5. Discussion 
 
This study comprehensively determined the metabolomics of the kl-/- mouse bone to 
identify novel pathologic factors with localization information using MALDI-IMS with 
fixation and decalcification.  
 
When preparing the cryosections of hard tissues without decalcification, the Kawamoto 
method requires cryofilm which can attach to the cutting surface under the freezing 
conditions [16]. Furthermore, for ionization, an electrically conducting double-adhesive 
tape is needed to set sections on the ITO-glass slide [2]. In a comparison of mass spectra 
between the sections with or without the tape, many more peaks were obtained from the 
section without the tape than another one. A method to remove the tape before applying 
to MALDI-IMS is reported [4], but a high degree of technical skill is required to do so. 
 
For MALDI-IMS, the fresh (without fixation) frozen sections were usually used for 
analysis. This study shows that the fixation and decalcification of bones makes 
preparation of sections easier and detection of MS from organic components is possible 
because of removing minerals. Since the usefulness of MALDI-IMS of formaline-fixed 
paraffin-embedded (FFPE) tissues was reported [17], the researchers have focused on 
analysis with FFPE samples in MALDI-IMS [18-24]. Formalin fixation can be used to 
avoid degradation and spoilage of samples, however, the cross-linked molecules 
between formalin and primary amines are unable to be ionized. Therefore, the number 
of identified proteins from FFPE sections is less than in cryosections, and several steps 
for removing formalin, breaking cross links, and cleaving of proteins to peptides are 
required [18, 24, 25]. If the targets are nucleotides, lipids, and peptides without primary 
amines, formalin does not form the cross-link and it is possible to apply the samples 
without such steps. Organic solvents such as ethanol can also fix the tissues by 
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coagulation and precipitation of proteins. Fixation with organic solvents has less 
interruption for MALDI-IMS, but dissolves away lipids from tissues. Based on these, 
fixation solution must be selected according to an object to be analyzed. 
 
Decalcification with EDTA or TCA was better than with formic acid to keep the tissue 
structures. Bone marrows were peeled from trabecular bone surfaces by formic acid 
decalcification, which can occur during the preparation of sections [26]. Treatment with 
TCA is useful because of a rapid one-step fixation and decalcification, which can 
preserve antigen and tissue morphology [27]. In this study, sections from TCA-treated 
samples were most suitable for examining both histology and comprehensive MS 
images.   
 
On the metabolomics of TCA-treated samples from kl-/- mouse bone with MALDI-IMS, 
some biomolecules were identified. Among of these, 2-hydroxyestradiol and 
sphingosine were focused on. 2-hydroxyestradiol is one of metabolites of estrogen and 
an immediate precursor of 2-methoxyestradiol, and previous studies reported that 
2-hydroxyestradiol inhibits osteoclast formation [28, 29]. Since both the number and the 
activity of osteoclasts are decreased in kl-/- mouse bone [30], these studies support our 
results that 2-hydroxyestradiol is detectable in the kl-/- mouse bone. The functions of 
sphingosine, a primary part of the sphingolipids, and its derivatives, including 
sphingosine 1 phosphate (S1P), on bone metabolism are complicated. In mouse 
calvaria-derived preosteoblast (MC3T3-E1) cultures, previous studies reported that 
sphingosine and S1P lead to intracellular calcium release [31, 32]. On the other hand, 
Kato et al. demonstrated that S1P induces heat shock protein 27, which has not only a 
stimulatory effect on mineralization but also an inhibitory effect on osteocalcin 
expression [33]. It is also suggested that S1P stimulates chondrocyte proliferation via 
ERK signaling in rat articular chondrocytes [34] and controls the migration of osteoclast 
precursors between bone tissues and the blood stream [35]. Further examination to 
 
42 
clarify the role of sphingosine in kl-/- is needed. 
This study successfully detected biomolecules in bones using MALDI-IMS. Although 
analytical procedures and compositional adjustment on device performance still require 
further development, MALDI-IMS appears to be a powerful tool for searching 
biomolecules even in bones.  
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6. Figure Legends 
 
Figure 1. Histological observations of femur and tibia fixed and decalcified with each 
solution by H-E, Alcian blue, Azan, and PAS staining. (A), the sections of 
unfixed/undecalcified tibiae. (B), the sections of TCA-treated femurs. (C)-(H), the 
sections of femurs with treatment of PFA/EDTA (C), Carnoy/EDTA (D), PFA/formic 
acid (E), or Carnoy/formic (F). (G, H), the unfixed sections of femurs with formic acid 
(G) or EDTA (H) decalcification. 
 
Figure 2. Mass spectra (maximum intensity) and MALDI-IMS of TCA-treated samples 
analyzed with MALDI-IMS in the range of m/z 100-1000 under the various conditions. 
(A, B), analysis with DHB matrix in the positive (A) or the negative (B) ion mode. (C, 
D), analysis with CHCA matrix in the positive (C) or the negative (D) ion mode. (E), 
imaging of histotypic distribution of several mass peaks on the sections. Left two 
images are of optical and H-E staining. (F, G), the mass spectra detected from the 
sections with (G) or without (F) a tape. 
 
Figure 3. Mass spectra (maximum intensity) of each treatment with MALDI-IMS in the 
range of 100 to 1000 and the positive ion mode with DHB. (A), the sections of 
unfixed/undecalcified tibiae. (B), the sections of TCA-treated femurs. (C)-(H), the 
sections of femurs with treatment of PFA/EDTA (C), Carnoy/EDTA (D), PFA/formic 
acid (E), or Carnoy/formic (F). (G, H), the unfixed sections of femurs with formic acid 
(G) or EDTA (H) decalcification. 
 
Figure 4. MALDI-IMS at m/z 554.57 and m/z 185.13 of each treatment. The left raw 
indicates the optical images. (A), the sections of unfixed/undecalcified tibiae. (B), the 
sections of TCA-treated femurs. (C)-(H), the sections of femurs with treatment of 
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PFA/EDTA (C), Carnoy/EDTA (D), PFA/formic acid (E), or Carnoy/formic (F). (G, 
H), the unfixed sections of femurs with formic acid (G) or EDTA (H) decalcification. 
 
Figure 5. Mass spectra (maximum intensity) detected by MALDI-IMS in range of 100 
to 700 and the positive ion mode with DHA of TCA-treated femurs derived from WT 
and kl-/- mice. Region of interest was selected in bones (A, B), cartilages (C, D), and 
bone marrows (E, F) from WT (A, C, E) and kl-/- (B, D, F) mouse bone.   
   
Figure 6. MALDI-IMS of femurs derived from kl-/- mouse at m/z 289.03 and m/z 
300.08. Upper panels show optical image (A) and H-E staining (B). Lower panels show 
MALDI-IMS images at m/z 289.03 (C) and m/z 300.08 (D). 
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A B C D E F G H 
Fixation ー 
TCA, 
 overnight 
PFA,   
overnight 
Carnoy, 
overnight 
PFA, 
 overnight 
Carnoy, 
overnight ー ー 
Decalcification ー EDTA,  
7 days 
EDTA,  
7 days 
Formic acid,  
2 days 
 Formic acid,  
2 days 
Formic acid,  
2 days 
EDTA,  
4 days 
Table 1. Combinations of fixation and decalcification solutions 
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Unfixed/undecalcified  TCA 
PFA/ 
EDTA  
Carnoy/ 
EDTA 
 PFA/ 
 Formic acid  
Carnoy/ 
Formic acid  
Unfixed/ 
Formic acid 
Unfixed/ 
EDTA 
m/z 100-400 165.07 114.91 114.91 114.91 184.08 114.91 114.91 114.91 
m/z 400-700 456.11 462.73 462.73 412.71 462.73 462.73 462.73 462.73 
Table 2. First principal component with or without pretreatment 
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Name Formula Weight Structure 
2-Hydroxyestradiol 288.3814 
 
 
C18H24O3 
 
   
   
   
   
   
Sphingosine 299.4919 
 
 
C18H37NO2 
 
   
   
Table 3. Metabolites estimated by HMDB  
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